This study investigated whether microvessel density (MVD) and mast cell infiltration are related to prognosis in non-small cell lung carcinoma (NSCLC), and examined the possible role of mast cells in NSCLC angiogenesis. MVD and mast cell infiltration were analysed retrospectively in tumour specimens from 50 patients with primary NSCLC. Immunohistochemistry with monoclonal antibody anti-CD34 was used to delineate the microvessels and routine Giemsa blue staining was used to assess the number of mast cells. Significant correlations were found between MVD and mast cell infiltration and between MVD and both lymph node metastasis and tumour, node, metastases (TNM) stage. No significant correlations were found with respect to survival for MVD or mast cell infiltration. Multivariate analysis showed that TNM stage and tumour size were independent predictors of survival, suggesting that the TNM staging system remains the most important tool for the estimation of prognosis in NSCLC patients.
Introduction
Lung cancer is the one of the most common malignancies in the USA and the leading cause of cancer death. The American Cancer Society reported that there were more than 160 000 deaths from lung cancer and more than 165 000 new cases diagnosed in 2003. 1 Histopathologically the majority of these tumours (80%) are classified as non-small cell lung carcinoma (NSCLC). 2 Five-year survival rates reported for stage I NSCLC range from 50 to 80%, and overall survival rates range from 10 to 15%. 2 Patients with the same stage of disease can show marked differences in terms of survival. Despite improvements in treatment protocols, the survival rate in NSCLC is mostly unchanged and further studies to delineate the biological pathways of these tumours are required.
The role of angiogenesis has been investigated in many types of tumours. It has been found to be a strong independent Mast cells and tumour angiogenesis in non-small cell lung carcinoma predictor of survival in cancer of the breast, 3 prostate, 4 skin, 5 larynx, 6 oral cavity, 7 bladder, 8 stomach 9 and large bowel. 10 For NSCLC, the importance of angiogenesis for prognosis is not yet clear: in some studies a correlation was found between a higher microvessel density (MVD) and more aggressive behaviour, 11 -19 but in other studies no such relationship was found. 20 -24 Tumour angiogenesis is a complex process mediated by angiogenic and antiangiogenic factors released from cancer cells and/or host immune cells. Among these host immune cells, several studies have indicated the role of mast cells in tumour progression via the promotion of angiogenesis. The mediators present in mast cell granules include basic fibroblast growth factor, interleukin (IL)-4, IL-8, tumour necrosis factor (TNF)-α and TNF-β, which are all strong inducers of angiogenesis. 25 Mast cell accumulation has been associated with enhanced growth and invasion in a variety of human cancers, including carcinoma of the breast, 26 stomach, 27 oesophagus, 28 oral cavity 29 and larynx, 30 and melanomas. 31 In contrast, the cytotoxic effect of mast cells on tumour cells has been shown in breast cancer and colorectal neoplasias. 32, 33 The significance of mast cell density in NSCLC appears less well defined 34 -39 and further studies are necessary.
In the present study, the correlation between MVD and mast cell infiltration was investigated in 50 cases of primary NSCLC using immunohistochemical and histochemical methods, and the effect of tumour angiogenesis and mast cell density on prognosis was evaluated.
Patients and methods

PATIENT SAMPLES
Tumour samples from primary NSCLC patients who had been treated surgically at Eskisehir Osmangazi University School of Medicine, Turkey, between 1990 and 2002 were reviewed. Haematoxylin and eosin stained sections of operation specimens were re-examined and a representative portion of NSCLC was chosen from each patient. Consecutive 5 µm thick sections were prepared for staining with avidin-biotin complex immunoperoxidase and Giemsa blue.
ASSESSMENT OF MICROVESSELS
For microvessel staining, sections from each tumour were dewaxed and heated in a microwave oven for 10 min to retrieve the antigens. Endogenous peroxidase was blocked by incubation with 3% hydrogen peroxide in methanol for 10 min. After incubation with primary antibody against CD34 (mouse monoclonal antibody, clone QBEnd/10, Neomarkers, Fremont, CA, USA) for 30 min, sections were reacted with secondary biotinylated antibody for 15 min and then with streptavidin for 15 min. Each incubation step was followed by thorough washing of the slides in distilled water and phosphate buffered saline. Finally, all slides were treated with aminoethylcarbazole reagent and counterstained with Mayer's haematoxylin.
Microvessels were assessed quantitatively using a double-headed light microscope without knowledge of the patient's outcome. Individual microvessels in the area of most intense vascularization (the hot spot), as described by Weidner et al., 3 were counted using a ×200 field (×20 objective and ×10 ocular lens; field of view, 0.723 mm 2 ). Any red-staining endothelial cell or endothelial cell cluster, with or without a lumen, that was clearly separate from neighbouring blood vessels, tumour cells and other connective tissue elements, was considered to be a microvessel. Branching vessels were counted as one vessel. Mast cells and tumour angiogenesis in non-small cell lung carcinoma
ASSESSMENT OF MAST CELLS
Mast cells were identified using routine Giemsa staining and were counted at the sites of the most intensive vascularization using the same method as that used to establish microvessel density.
STATISTICAL ANALYSIS
Statistical analysis was performed using SPSS ® for Windows ® version 11.0 (SPSS Inc., Chicago, IL, USA).
The correlation between MVD and mast cell infiltration was assessed using the Pearson correlation test. Spearman's rank correlation coefficient was used to analyse the association between the clinicopathological parameters of age, sex, histological type of tumour, tumour stage, lymph node metastasis, MVD and mast cell infiltration. Post-operative survival was analysed using the Kaplan-Meier method. The influence of clinicopathological factors, MVD and mast cell infiltration on overall survival was assessed using multivariate analysis with the Cox proportional hazards model to identify independent prognostic factors. A P-value < 0.05 was considered to be statistically significant. Data are expressed as means ± SE.
Results
Tumour samples from 50 primary NSCLC patients (46 men and four women) were reviewed. The mean age of the patients was 59 years (range 40 -77 years). The mean ± SE follow-up period was 51.27 ± 8.10 months (range 1 -127 months). All the patients had normal abdominal and brain computed tomograms and radionuclide bone scans.
The clinicopathological characteristics of the patients studied are shown in Table 1 , and the density of microvessels and mast cells in relation to various patient and clinicopathological tumour parameters are shown in Table 2 .
Blood vessels were heterogeneously distributed in the stroma of the tumours. The mean ± SE number of microvessels counted Clinicopathological characteristics of the non-small cell lung carcinoma patients studied (n = 50) Mast cells and tumour angiogenesis in non-small cell lung carcinoma in a ×200 field was 80.08 ± 4.41, (range 31 -200); a typical field is shown in Fig. 1 . A higher percentage of patients with lymph node metastasis had more microvessels than the mean (i.e. > 80 microvessels) compared with patients without metastasis (Table 2) ; the mean ± SE microvessel count was higher in patients with lymph node metastasis than in those without metastasis (70.10 ± 21.82 versus 95.05 ± 37.30). In addition, the percentage of cases with more microvessels than the mean was greater in tumour, node, metastases (TNM) stages II and III compared with stage I ( Table 2) . There was a significant correlation between MVD and both lymph node metastasis (P < 0.01) and TNM stage (P < 0.05). No significant correlations were found between MVD and age, sex, histological type or tumour size. Mast cells were often observed in small groups around the invasive edge of the tumour tissue, especially where the MVD was high. The mean ± SE number of mast cells counted in a ×200 field was 8.33 ± 1.1 (range 1 -120); a typical field is shown in Fig. 2 . The Pearson correlation test revealed a significant correlation between MVD and mast cell density (P < 0.01). Although the mean mast cell count was higher in patients with lymph node metastasis compared with patients without lymph node metastasis (11.75 ± 25.90 versus 6.10 ± 6.019), this difference was not statistically significant. No significant correlations were found between mast cell density and age, sex, tumour size, histological type, lymph node metastasis or TNM stage.
TABLE 2: Patient and clinicopathological characteristics related to microvessel (anti-CD34 antibodylabelled) and mast cell densities in non-small cell lung carcinoma patients (n = 50)
Microvessel density (MVD)
Mast 
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There were no significant correlations between survival and age, sex, histological type of the tumour, MVD or mast cell density. Multivariate analysis using the Cox proportional hazards model showed that TNM stage and tumour size were independent prognostic factors.
Discussion
Angiogenesis is a biological process by which new blood vessels develop from the endothelium of pre-existing vasculature. Recent evidence suggests that tumour angiogenesis is associated with patient outcome in a number of malignancies, including carcinomas of the breast, prostate, skin, larynx, oral cavity, bladder, stomach and large bowel. 3 -10 More than 160 studies focusing on angiogenesis and its relationship to prognosis in NSCLC have been reported in the English literature. While some have suggested that angiogenesis might be an independent prognostic factor, others have failed to show any relationship between tumour vascularization and survival. The results to date are not clear, therefore, and the clinical implications are inconclusive. Macchiarini et al. 11 reported that angiogenesis was closely associated with metastasis in NSCLC. Fontanini et al. 12 determined that the mean microvessel count was significantly lower in normal, hyperplastic and squamous metaplastic epithelium than in dysplastic epithelium, in situ carcinoma and invasive carcinoma. Yamazaki et al. 13 found that angiogenesis was positively correlated with relapse in adenocarcinoma of the lung; they also suggested that microvessel count was associated with tumour aggressiveness. In the study by Matsuyama et al., 14 tumour vascularity was shown to be an independent prognostic factor and angiogenesis in primary tumours was significantly correlated with the development of haematogenous metastases. Shibusa et al., 15 Ohta et al., 16 Duarte et al. 17 and Imoto et al. 18 all reported that the mean MVD in tumours with recurrence was significantly greater than in tumours without recurrence in stage I NSCLC. In contrast, Tanaka et al., 19 Chandrachud et al., 20 Brattstrom et al., 21 Tsoli et al., 22 Dazzi et al. 23 and Decaussin et al. 24 showed that angiogenesis within the tumour did not significantly influence survival in patients with NSCLC.
In the present study, Kaplan-Meier plots of survival showed that there was no correlation between MVD and survival in NSCLC patients. On multivariate analysis TNM stage and tumour size were found to be independent predictors of survival. Although no statistically significant correlation was found between MVD and survival, the presence of a significant correlation between MVD and both lymph node metastasis and TNM stage may point to the promoting effect of increased vascularity on tumour progression.
The exact mechanism of tumour angiogenesis is not definitively understood. Recently mast cells have been investigated in many types of tumour due to their possible role in angiogenesis. It is well known that several mast cell mediators, including IL-4, IL-8, TNF-α, TNF-β, histamine, basic fibroblast growth factor and heparin, are angiogenic and regulate endothelial proliferation and function. 25 In contrast, an anti-tumour effect of mast cells has been reported in breast cancer 32 and colorectal carcinomas. 33 In NSCLC, the importance of mast cell infiltration for prognosis is still controversial and there are few studies on this subject. 34 -39 Tomita et al. 37 and Welsh et al. 35 found a close relationship between the number of mast cells and a good prognosis in NSCLC. Ibaraki et al., 36 Takanami et al. 38 and Tomita Mast cells and tumour angiogenesis in non-small cell lung carcinoma et al. 39 reported a significant correlation between the number of mast cells and MVD in NSCLC. Takanami et al. 38 and Tomita et al. 39 concluded that a higher number of mast cells is associated with a poor prognosis. In a study by Tataroglu et al., 34 mast cell density was shown to be higher in the early stages of the tumour, supporting their suggested role in the fight against cancer, but no correlation was found between mast cell density and angiogenesis.
In the present study, a significant correlation was shown between MVD and mast cell density, but not between mast cell density and survival. Mast cells may have different functions, such as cytotoxicity or angiogenic activity, in the different phases of tumour growth, or phenotypically different mast cells may exist in different tumours. Further studies are required to determine whether mast cells enhance host immunity against cancer or promote tumour growth by inducing angiogenesis.
In conclusion, no direct correlation was found in the present study between survival and MVD or mast cell density, although the presence of a significant correlation between MVD and both lymph node metastasis and TNM stage may indicate the impact of vascularity on tumour progression. Despite the large number of investigations performed to evaluate prognostic factors in NSCLC, the results of the present study confirm that TNM staging remains the most important tool for the estimation of prognosis in these patients.
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